Article Details

Mablink Bioscience, the next generation ADC company, raises €4 Million to move forward its ADC ...

Retrieved on: 2021-04-27 12:11:15

Tags for this article:

Click the tags to see associated articles and topics

Mablink Bioscience, the next generation ADC company, raises €4 Million to move forward its ADC .... View article details on hiswai:

Excerpt

ADC is a new class of drugs that work like a guided missile: a monoclonal antibody is used to transport physically linked highly potent cytotoxic ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up